Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

M2-mAChRs as therapeutic targets for treating substance use disorders

July 28, 2022

Clearmind reports safety and reduced alcohol consumption with combination of MEAI and CannAmide

May 25, 2022

Clearmind's MEAI shows suppressive effect on alcohol consumption in mice

May 20, 2022

Novel selective D3R ligands for the treatment of drug addiction

May 19, 2022

M1 mAChR antagonism attenuates opioid drug seeking behaviors in rat

May 5, 2022

CNRS and collaborators patent acetylcholinesterase reactivators

April 1, 2022

Red Bull GmbH presents dopamine reuptake inhibitors

Jan. 20, 2022

Metabotropic glutamate mGlu2 receptor found to be associated with alcoholism

Nov. 30, 2021

Researchers develop a rat model of oxycodone/cocaine withdrawal syndrome

Nov. 23, 2021

One-year challenge data from preclinical study of ATI-1701 in lethal model of tularemia

Nov. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...